PATENT CLAIM ANALYSIS

Application Number: 15866001
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "133100"]

Abstract:
The present invention is related to a method for treating cancer metastasis and composition thereof. By using an IL-35 antagonist, cancer metastasis can be effectively treated so that an increased cancer fee and overall survival can be achieved.

Claim (Index 14):
A method for treating cancer, comprising:\n (a) administering a subject in need with a primary cancer treatment; and (b) administering said subject a therapeutically effective amount of an anti-IL-35 antibody or antigen-binding fragment thereof or a shRNA against the expression of IL12RB2 and a therapeutically effective amount of an anti-CSF1R antibody or antigen-binding fragment thereof; wherein said cancer is breast cancer, non-small cell lung cancer, gastric cancer, head and neck cancer, colon cancer, pancreatic cancer, ovarian cancer, or oral cancer.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.24242
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13634392', '15402141', '14562306', '14478175', '14661656']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6973113390782569
- 35 USC 102 Novelty (BERT): 0.5036311225467911
- Combined Prediction Score: 0.6779433174251104
- Mean Citation Score: 275.17931400000003
- Max Citation Score: 283.3375200000001
- Similarity Product: 221.0337069763613

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test